Antineoplastic agents, 256. Cell growth inhibitory isocarbostyrlls from Hymenocallis

Journal of Natural Products

Volumn 56, Issue 10, 1993, Pages 1682-1687

  Pettit, George R ^a,a   Backhaus, Ralph A ^a   Boyd, Michael R ^b   Meerow, Alan W ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NARCICLASINE; PANCRATISTATIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CYTOPATHOGENIC EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMAN; ISOQUINOLINES; PLANTS, MEDICINAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

HYMENOCALLIS; HYMENOCALLIS CARIBAEA; HYMENOCALLIS LATIFOLIA; HYMENOCALLIS LITTORALIS;

EID: 0027429002     PISSN: 01633864     EISSN: 15206025     Source Type: Journal    
DOI: 10.1021/np50100a004     Document Type: Article

References (23)

1. R.F. Ludueña, M.C. Roach, V. Prasad, and G.R. Pettit, Biochem. Pharmacol., 43, 539 (1992).
2. J.B. Gardeil (translator), “Traduction des Oeuvres Médicales d'Hippocrate,” Fages, Meilhec et Cie, Toulouse, 4 vols. 1801.
3. S.F. Martin, in: “The Alkaloids.” Ed. by A. Brossi, Academic Press, New York, 1987, Vol. 30, pp. 251–376.
4. R.D. Gibbs, “Chemotaxonomy of Flowering Plants,” McGill-Queen's University Press, Montreal, 1974, Vol. III, p. 1924.
5. E. Tojo, J. Nat. Prod, 54, 1387 (1991).
6. J. Bastida, C. Codina, F. Viladomat, M. Rubiralta, J.-C. Quirion, and B. Weniger, J. Nat. Prod., 55, 137 (1992).
7. J. Bastida, C. Codina, F. Viladomat, M. Rubiralta, J.-C. Quirion, and B. Weniger, J. Nat. Prod., 55, 122 (1992).
8. Plinius Secundus, C. (Pliny the Elder), “Natural History.” Translated by J. Bostock and H.T. Riley, Bohn, London, 6 vols., 1855.
9. J.L. Hartwell, Uoydia, 30, 379 (1967).
10. B.F. Kosteletzky, “Allgemeine medizinisch-pharmazeutische Flora,” Borrosch and Andre, Prague, 6 vols., 1831–1836.
11. G.R. Pettit, V. Gaddamidi, D.L. Herald, S.B. Singh, G.M. Cragg, J.M. Schmidt, F.E. Boettner, M. Williams, and Y. Sagawa, J. Nat. Prod, 49, 995 (1986).
12. B. Gabrielsen, T.P. Monath, J.W. Huggins, D.F. Kefauver, G.R. Pettit, G. Groszek, M. Hollingshead, J.J. Kirsi, W.M. Shannon, E.M. Schubert, J. Dare, B. Ugarkar, M.A. Ussery, and M.J. Phelan, J. Nat. Prod., 55, 1569 (1992).
13. S. Danishefsky and J.Y. Lee, J. Am. Chem. Soc., 111, 4829 (1989).
14. G.R. Pettit, Y. Fujii, J.A. Hasler, J.M. Schmidt, and C. Michel J. Nat. Prod., 45, 263 (1982).
15. T. Okamota, Y. Torii, and H. Isotani, Japan 71 00,253 (Cl.A 01 n, C07d), 06 Jan 1971, Appl. 28 Mar. 1967;
16. Chem. Abstr., 75, 128753 (1971).
17. T. Okamoto, Y. Torii, and Y. Isogai, Chem. Pharm. Bull., 16, 1860 (1968).
18. K. Isobe and J.-I. Taga, Heterocycles, 9, 625 (1978).
19. M.R. Boyd, in: “Principles and Practices of Oncology Update.” Ed. by V.T. DeVita Jr., S. Hellman, and S.A. Rosenberg, Lippincott, Philadelphia, 1989, Vol. 3, No. 10, pp. 1–12.
20. M.R. Boyd, K.D. Paull, and L.R. Rubinstein, in: “Antitumor Drug Discovery and Development.” Ed. by F.A. Valeriote, T. Corbett, and L. Baker, Kluwer Academic Press, Amsterdam, 1992, pp. 11–34.
21. K.D. Paull, R.H. Shoemaker, L. Hodes, A. Monks, D.A. Scudiero, L. Rubinstein, J. Plowman, and M.R. Boyd J. Natl. Cancer Inst., 81, 1088 (1989).
22. R.A. Backhaus, G.R. Pettit III, D.S. Huang, G.G. Groszek, A.W. Merrow, and J. Odgers, Acta Horticulture, 295, 364 (1992).
23. A. Monks, D. Scudiero, P. Skehan, R. Shoemaker, K. Paull, D. Vistica, C. Hose, J. Langley, P. Cronise, A. Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, and M.R. Boyd, J. Natl. Cancer Inst., 83, 757 (1991).